Proteome Sciences plc (LON:PRM – Get Free Report) shares were up 9% during trading on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). Approximately 967,070 shares traded hands during trading, an increase of 496% from the average daily volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Price Performance
The company has a market capitalization of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07. The business’s 50-day moving average price is GBX 2.73 and its two-hundred day moving average price is GBX 3.15.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 2 Drone Stocks Surging from Increased Media Attention
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
